NOTABLE LABS LTD (NTBL) Fundamental Analysis & Valuation

NASDAQ:NTBL • IL0012002452

Current stock price

0.2479 USD
-0.09 (-27.68%)
At close:
0.2456 USD
0 (-0.93%)
After Hours:

This NTBL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. NTBL Profitability Analysis

1.1 Basic Checks

  • NTBL had negative earnings in the past year.
  • In the past year NTBL has reported a negative cash flow from operations.
  • In the past 5 years NTBL always reported negative net income.
  • NTBL had a negative operating cash flow in each of the past 5 years.
NTBL Yearly Net Income VS EBIT VS OCF VS FCFNTBL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

  • NTBL has a Return On Assets of -152.09%. This is amonst the worse of the industry: NTBL underperforms 86.15% of its industry peers.
  • Looking at the Return On Equity, with a value of -232.90%, NTBL is doing worse than 71.23% of the companies in the same industry.
Industry RankSector Rank
ROA -152.09%
ROE -232.9%
ROIC N/A
ROA(3y)-70.94%
ROA(5y)-62.1%
ROE(3y)-91.91%
ROE(5y)-81.59%
ROIC(3y)N/A
ROIC(5y)N/A
NTBL Yearly ROA, ROE, ROICNTBL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -50 -100

1.3 Margins

  • NTBL has a Gross Margin of 37.70%. This is in the better half of the industry: NTBL outperforms 76.91% of its industry peers.
  • In the last couple of years the Gross Margin of NTBL has declined.
  • The Profit Margin and Operating Margin are not available for NTBL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.15%
GM growth 5Y-8.21%
NTBL Yearly Profit, Operating, Gross MarginsNTBL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K -4K

3

2. NTBL Health Analysis

2.1 Basic Checks

  • NTBL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for NTBL has been increased compared to 1 year ago.
  • NTBL has a worse debt/assets ratio than last year.
NTBL Yearly Shares OutstandingNTBL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
NTBL Yearly Total Debt VS Total AssetsNTBL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

  • NTBL has an Altman-Z score of -16.80. This is a bad value and indicates that NTBL is not financially healthy and even has some risk of bankruptcy.
  • NTBL has a worse Altman-Z score (-16.80) than 84.55% of its industry peers.
  • A Debt/Equity ratio of 0.03 indicates that NTBL is not too dependend on debt financing.
  • NTBL has a Debt to Equity ratio (0.03) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -16.8
ROIC/WACCN/A
WACC10.75%
NTBL Yearly LT Debt VS Equity VS FCFNTBL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

2.3 Liquidity

  • NTBL has a Current Ratio of 2.77. This indicates that NTBL is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of NTBL (2.77) is worse than 68.56% of its industry peers.
  • A Quick Ratio of 2.77 indicates that NTBL has no problem at all paying its short term obligations.
  • NTBL's Quick ratio of 2.77 is on the low side compared to the rest of the industry. NTBL is outperformed by 67.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.77
Quick Ratio 2.77
NTBL Yearly Current Assets VS Current LiabilitesNTBL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

0

3. NTBL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 65.56% over the past year.
  • The Revenue for NTBL has decreased by -34.79% in the past year. This is quite bad
  • NTBL shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.08% yearly.
EPS 1Y (TTM)65.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-41.52%
Revenue 1Y (TTM)-34.79%
Revenue growth 3Y-30.41%
Revenue growth 5Y-12.08%
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, NTBL will show a very negative growth in Earnings Per Share. The EPS will decrease by -63.21% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-81.59%
EPS Next 2Y-63.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NTBL Yearly Revenue VS EstimatesNTBL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
NTBL Yearly EPS VS EstimatesNTBL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5 -10 -15

0

4. NTBL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NTBL. In the last year negative earnings were reported.
  • Also next year NTBL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NTBL Price Earnings VS Forward Price EarningsNTBL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NTBL Per share dataNTBL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

  • NTBL's earnings are expected to decrease with -63.21% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-63.21%
EPS Next 3YN/A

0

5. NTBL Dividend Analysis

5.1 Amount

  • NTBL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NTBL Fundamentals: All Metrics, Ratios and Statistics

NOTABLE LABS LTD

NASDAQ:NTBL (10/22/2024, 8:00:02 PM)

After market: 0.2456 0 (-0.93%)

0.2479

-0.09 (-27.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-14
Earnings (Next)11-12
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners16.5%
Ins Owner Change0%
Market Cap2.39M
Revenue(TTM)313.00K
Net Income(TTM)-16.74M
Analysts80
Price Target9.18 (3603.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.38%
Min EPS beat(2)-25.98%
Max EPS beat(2)-4.77%
EPS beat(4)0
Avg EPS beat(4)-294.73%
Min EPS beat(4)-1133.4%
Max EPS beat(4)-4.77%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-31.6%
EPS NY rev (1m)0%
EPS NY rev (3m)-27.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.65
P/FCF N/A
P/OCF N/A
P/B 0.33
P/tB 0.33
EV/EBITDA N/A
EPS(TTM)-6.91
EYN/A
EPS(NY)-3.63
Fwd EYN/A
FCF(TTM)-1.76
FCFYN/A
OCF(TTM)-1.75
OCFYN/A
SpS0.03
BVpS0.74
TBVpS0.74
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -152.09%
ROE -232.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.7%
FCFM N/A
ROA(3y)-70.94%
ROA(5y)-62.1%
ROE(3y)-91.91%
ROE(5y)-81.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.15%
GM growth 5Y-8.21%
F-Score1
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.83%
Cap/Sales 25.56%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.77
Quick Ratio 2.77
Altman-Z -16.8
F-Score1
WACC10.75%
ROIC/WACCN/A
Cap/Depr(3y)72.79%
Cap/Depr(5y)45.66%
Cap/Sales(3y)111.54%
Cap/Sales(5y)70.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-41.52%
EPS Next Y-81.59%
EPS Next 2Y-63.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-34.79%
Revenue growth 3Y-30.41%
Revenue growth 5Y-12.08%
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-24.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y46.33%
OCF growth 3YN/A
OCF growth 5YN/A

NOTABLE LABS LTD / NTBL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NOTABLE LABS LTD (NTBL) stock?

ChartMill assigns a fundamental rating of 1 / 10 to NTBL.


What is the valuation status of NOTABLE LABS LTD (NTBL) stock?

ChartMill assigns a valuation rating of 0 / 10 to NOTABLE LABS LTD (NTBL). This can be considered as Overvalued.


How profitable is NOTABLE LABS LTD (NTBL) stock?

NOTABLE LABS LTD (NTBL) has a profitability rating of 1 / 10.